Patents by Inventor Xinbei Jiang

Xinbei Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phenylmethyl-piperazine derivatives and antiviral uses thereof
    Patent number: 11939307
    Abstract: Disclosed are a benzyl piperazine compound, a preparation method there for and an application thereof in an antivirus. The benzyl piperazine compound has a structure represented by the following general formula(I). It is proven by experiments that the benzyl piperazine compound not only has significant antiviral activity, but also has the advantages of low cytotoxicity, a high selectivity index and soon.
    Type: Grant
    Filed: November 29, 2019
    Date of Patent: March 26, 2024
    Assignee: INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES
    Inventors: Yanping Li, Zhuorong Li, Zonggen Peng, Xinbei Jiang, Yixuan Wang, Jianrui Li, Jiali Tan
  • BENZYL PIPERAZINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN ANTIVIRUS
    Publication number: 20230024612
    Abstract: Disclosed are a benzyl piperazine compound, a preparation method there for and an application thereof in an antivirus. The benzyl piperazine compound has a structure represented by the following general formula(I). It is proven by experiments that the benzyl piperazine compound not only has significant antiviral activity, but also has the advantages of low cytotoxicity, a high selectivity index and soon.
    Type: Application
    Filed: November 29, 2019
    Publication date: January 26, 2023
    Inventors: Yanping LI, Zhuorong LI, Zonggen PENG, Xinbei JIANG, Yixuan WANG, Jianrui LI, Jiali TAN
  • Type of antiviral compound
    Patent number: 10252987
    Abstract: Provided are a new aromatic cyanogen compound and a preparation method thereof. The present invention also relates to the use of such compound in antiviral drugs, in particular the use thereof in anti-HCV drugs.
    Type: Grant
    Filed: August 17, 2016
    Date of Patent: April 9, 2019
    Assignee: Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
    Inventors: Yanping Li, Zhuorong Li, Zonggen Peng, Jianrui Li, Xinbei Jiang, Jinhua Chen, Jiandong Jiang
  • NEW TYPE OF ANTIVIRAL COMPOUND
    Publication number: 20180208549
    Abstract: Provided are a new aromatic cyanogen compound and a preparation method thereof. The present invention also relates to the use of such compound in antiviral drugs, in particular the use thereof in anti-HCV drugs.
    Type: Application
    Filed: August 17, 2016
    Publication date: July 26, 2018
    Inventors: Yanping Li, Zhuorong Li, Zonggen Peng, Jianrui Li, Xinbei Jiang, Jinhua Chen, Jiandong Jiang